Nurotech Development Corporation (OTCBB: NURO)
Current Price: $0.178
Shares Outstanding: 117M
Public Float: 81M
Average Daily Volume: 417K

Chart for NURO ( Chart via PCQuote)

Corporate Profile

Neurotech Development Corporation is an international, single-source designer, developer and builder of pre-engineered, rapid deployment hospitals, medical clinics, and health care facilities. Neurotech provides requisite primary health care products and services to its client countries. The development and operation of these facilities are supported by the Company's "Neurotech HealthCare System©". Internet and proprietary Intranet architecture provide global medical and health care connectivity. Neurotech's current backlog is $1,514,000,000 for health care facilities, schools and services from two principal client countries, China and Indonesia.

USA standards of medical technology, diagnostics, physician and health care personnel training, computers, telephony, and resource management software systems provide turn-key health care facilities that meet and exceed Neurotech's client countries', national health care requirements. Client countries' health care personnel are trained at USA based medical teaching universities in diagnostics, health care management, and facilities operation and administration. When training is complete, client countries' heath care personnel are qualified to manage and operate Neurotech's "turn-key" medical facilities.

China: According to new strategic research (F&S Report) conducted by Frost & Sullivan, "Chinese Diagnostic Product Markets"... "the Chinese market is expected to grow at a compound annual rate of 16.3% from 1999 through 2005. The vast Chinese population, a large portion of which is aging, will spur demand for diagnostic products". The Frost & Sullivan report adds, "the establishment of new hospitals and nursing homes catering to the growing health care needs of the Chinese, will further this demand. Health care reforms will bolster market…Chinese health care reform programs will establish more hospitals and nursing homes ".

Chinese leaders must deal with a rising gray tide, states that, “some 126 million Chinese, or one out of 10 people, are aged 60 or older (largest elderly population in the world). By 2030, caring for a projected 300 million elderly could consume 10% of China’s national income. Policies are being drafted to encourage growth of a geriatric care industry.” Neurotech Development’s $30,000,000 USD dollar geriatric facility, under contract in Southern Guandong, cited in the article, portends enormous supply opportunities for the Company in this health care, market segment.

The Neurotech HealthCare System©

Neurotech Development completed final development of its proprietary rapid deployment managed health care system after four years of prototyping, modeling, and successful operational trials. The Company's production ready, proprietary System through computers and telephony, will link client countries' health care facilities with USA and other internationally based hospitals, universities, medical research institutions, medical organizations, physician referral services, medical journals and libraries, laboratories, professional medical and business societies, associations, institutes and organizations, providing global Internet and Intranet connectivity.

Year 2001 Building & Development

For latest developments, please refer to the Neurotech Development Corporation Asia News Update page.

Indonesia: The company currently holds $100,000,000 in bank guarantees from its clients in Indonesia. Current economic instability of the financial institutions and government may prevent the company from starting the planned construction of these facilities in October 2001 upon maturity of the bank guarantees. The company will closely monitor the situation, and communications remain close. Geological and site analysis for five hospitals have been completed. The Company intends to build and complete six hospitals once construction begins.

China: The Company has orders for hospitals and health care facilities totaling USD $635,000,000. Construction of Neurotech health care facilities is scheduled to start in November of 2000. Neurotech estimates this project's completion sometime in late 2003.

Investment, Acquisitions and Business Development

Neurotech has acquired 12.5% of American International Medical Resources, Inc. (AIM), and intends to complete the acquisition, which includes Residential Health Care, Inc. (RHC).

Residential Health Care provides health care containment services offering utilization review, pre-certification, concurrent review, retro-review, discharge planning, and large case management to approximately 200 customers. RHC's customers are insurance companies, third party administrators, self-insured employers, and other health care purchasing groups. Connected to RHC are 300,000 USA Physicians/MD's, 3600 acute care hospitals, and 22,600 ancillary service facilities, including medical research, universities and interconnected supporting medical record and information databases.

When the acquisition of AIM is completed, and AIM completes the RHC acquisition, Neurotech will incorporate AIM's/RHC's databases, customers, vendors, and other associated product and service providers into its Neurotech HealthCare System©. Neurotech will leverage this core base to develop and expand its products and services offerings.

Doctors4Doctors.net: Neurotech which owns the "Doctors4Doctors.net" and "Doctors4Doctors.org" domain names is developing an Internet and Intranet portal that will provide the electronic architecture for its USA based and overseas Physicians' connectivity to the "Neurotech HealthCare System©". Physicians and health care professionals, practicing in industrializing and developing countries, that have been geographically and technologically limited in improving their health care practices and modalities, will now be able to significantly advance their standards utilizing the Doctors4Doctors.net© on-line tele-medicine services providing on-line video conferencing, supplies and equipment, diagnostics, physician referrals, pharmacological data and information, surgical procedure training, disease research, treatment case studies, and continuing education courses.

Neurotech Development Corporation expects the intended combination of AIM and Doctors4Doctors will produce significant, increasing, recurring revenues.

On-line Investor Resources

Market Guide - Snapshot for Neurotech Development Corporation
Ziff Davis Net Inter@ctive Investor

FreeEdgar Filings

Other Sources: Vertical Capital Partners Inc. Neurotech Report

News Releases ( From Yahoo Finance)

Certain statements in this Corporate Profile constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risk, uncertainties and other factors that may cause actual results to differ materially from the anticipated results, performance, of achievements expressed or implied by such forward-looking statements. Such factors include but are not limited to changing economic conditions, changes in government regulations and budgets, language and translation, issuance of permits, import licenses, work visas, education visas, availability of class positions, changing economic conditions, competition as well as commercial and political risks.

OTC Opportunity News and its "Report" are not a registered investment advisor, a broker-dealer and/or a broker. All statements and expressions are strictly the opinions of OTC Opportunity News, the statements and expressions made are not meant to be a solicitation to buy or sell securities. We at OTC Opportunity News believe all sources of information to be reliable but make no representation or guarantee to the accuracy of the information provided. The information that OTC Opportunity News relies on is, generally provided by the company featured and will also use every attempt possible to include all information available from outside sources. Investors should not only rely solely on the information contained in this publication. Rather investors should use the information provided as a starting point for doing additional research to form his or her opinions. Understand that trading or investing in any securities involves a high degree of risk and use of the information provided is at the investor’s sole risk. Know your risk limitations. OTC Opportunity News and its publishers are not liable for any losses, damage’s, monetary or otherwise, that may occur due to the content of OTC Opportunity News or its Report. The matters in this report contain forward looking statements, as defined in section 27(A) of the securities act of 1933 and section 21(E) of the security exchange act of 1934 as amended. OTC Opportunity News may act as a consultant to these companies reviewed in this publication. Investors should be made aware that companies featured might pay consideration to OTC Opportunity News and/or it shareholders.OTC Opportunity News editor or affiliate, agents and/or family. OTC Opportunity News expects to receive two thousand dollars in cash from L.B. Internet Consulting. for services rendered to the company profiled in this publication. OTC Opportunity News may acquire a position in the company herein profiled. Some of the shares acquired may have been acquired prior to the dissemination of this report and OTC Opportunity News may increase or decrease these positions at any time.